What does PHARMACIE HITTELET do?

PHARMACIE HITTELET is a logistics company in Etalle. Private Limited, started on 20 December 1990, 1 establishment.

What is the address of PHARMACIE HITTELET?

The registered office of PHARMACIE HITTELET is located at Lenclos 72 box A, 6740 Etalle.

Is PHARMACIE HITTELET still active?

Yes. According to the CBE (29 October 2026) PHARMACIE HITTELET is active, legal situation “Normale toestand”, started on 20 December 1990.

Is PHARMACIE HITTELET registered on Peppol?

Yes, PHARMACIE HITTELET is registered on the Peppol network with ID 0208:0442591697.

What is the enterprise number of PHARMACIE HITTELET?

The enterprise number of PHARMACIE HITTELET is BE0442591697.

When was PHARMACIE HITTELET founded?

PHARMACIE HITTELET was founded on 20 December 1990.

Who are the directors of PHARMACIE HITTELET?

According to the 2025 annual accounts, the directors of PHARMACIE HITTELET are: Joëlle Denis, Olivier Groffy.

Is PHARMACIE HITTELET a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 December 1990; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARMACIE HITTELET make in 2025?

PHARMACIE HITTELET posted a profit after taxes of € 52,563 in financial year 2025.

What is the revenue of PHARMACIE HITTELET?

As a small company, PHARMACIE HITTELET is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 401,959.

How much does an employee at PHARMACIE HITTELET earn?

The average wage cost per full-time employee at PHARMACIE HITTELET was € 68,300 in 2025: staff costs of € 273,376 for 4 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE HITTELET have?

According to the 2025 annual accounts, PHARMACIE HITTELET has 4 full-time equivalents (FTE).

PHARMACIE HITTELET (Private Limited) - Etalle

Dossier PHARMACIE HITTELET, printed on 29 October 2026 from databakkes.be/en/0442591697/pharmacie-hittelet. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 39 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHARMACIE HITTELET from Etalle, company number BE0442591697, closed financial year 2025 with a result of € 52,563 after tax. For that financial year PHARMACIE HITTELET recorded a gross margin of € 401,959 and equity of € 270,030. Compared with financial year 2024, the result moved from € 40,602 to € 52,563. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 20, 2026.

What it is worth Growing

€ 270,030

▲ 24% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 52,563

▲ 29% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 58,959

▲ 59% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 245,240.

People and assets in 2025

Full-time equivalents

▼ 0.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 273,376

▼ 7% vs 2024

€ 68,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 468,476

▼ 15% vs 2024

€ 89,866 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 95,130

▼ 14% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 37,726

▲ 19% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 394,050 Gross margin 2022: € 394,050 First fiscal year in the series	€ 370,251 Gross margin 2023: € 370,251 ▼ 6% vs 2022 (€ 394,050) Unfavourable step	€ 410,072 Gross margin 2024: € 410,072 ▲ 11% vs 2023 (€ 370,251) Favourable step	€ 401,959 Gross margin 2025: € 401,959 ▼ 2% vs 2024 (€ 410,072) Unfavourable step	▼ 2%
Profit after taxes	€ 68,444 Profit after taxes 2022: € 68,444 First fiscal year in the series	€ 52,721 Profit after taxes 2023: € 52,721 ▼ 23% vs 2022 (€ 68,444) Unfavourable step	€ 40,602 Profit after taxes 2024: € 40,602 ▼ 23% vs 2023 (€ 52,721) Unfavourable step	€ 52,563 Profit after taxes 2025: € 52,563 ▲ 29% vs 2024 (€ 40,602) Favourable step	▲ 29%
Equity	€ 124,144 Equity 2022: € 124,144 First fiscal year in the series	€ 176,864 Equity 2023: € 176,864 ▲ 42% vs 2022 (€ 124,144) Favourable step	€ 217,467 Equity 2024: € 217,467 ▲ 23% vs 2023 (€ 176,864) Favourable step	€ 270,030 Equity 2025: € 270,030 ▲ 24% vs 2024 (€ 217,467) Favourable step	▲ 24%
Total debts	€ 1,041,416 Total debts 2022: € 1,041,416 First fiscal year in the series	€ 889,783 Total debts 2023: € 889,783 ▼ 15% vs 2022 (€ 1,041,416) Favourable step	€ 815,380 Total debts 2024: € 815,380 ▼ 8% vs 2023 (€ 889,783) Favourable step	€ 758,734 Total debts 2025: € 758,734 ▼ 7% vs 2024 (€ 815,380) Favourable step	▼ 7%
Cash	€ 51,105 Cash 2022: € 51,105 First fiscal year in the series	€ 64,925 Cash 2023: € 64,925 ▲ 27% vs 2022 (€ 51,105) Favourable step	€ 37,079 Cash 2024: € 37,079 ▼ 43% vs 2023 (€ 64,925) Unfavourable step	€ 58,959 Cash 2025: € 58,959 ▲ 59% vs 2024 (€ 37,079) Favourable step	▲ 59%
Land & buildings	€ 778,227 Land & buildings 2022: € 778,227 First fiscal year in the series	€ 749,149 Land & buildings 2023: € 749,149 ▼ 4% vs 2022 (€ 778,227) Unchanged	€ 720,070 Land & buildings 2024: € 720,070 ▼ 4% vs 2023 (€ 749,149) Unchanged	€ 690,992 Land & buildings 2025: € 690,992 ▼ 4% vs 2024 (€ 720,070) Unchanged	▼ 4%
Retained profit	€ 99,354 Retained profit 2022: € 99,354 First fiscal year in the series	€ 152,075 Retained profit 2023: € 152,075 ▲ 53% vs 2022 (€ 99,354) Favourable step	€ 192,677 Retained profit 2024: € 192,677 ▲ 27% vs 2023 (€ 152,075) Favourable step	€ 245,240 Retained profit 2025: € 245,240 ▲ 27% vs 2024 (€ 192,677) Favourable step	▲ 27%
Dividend	€ 50,000 Dividend 2022: € 50,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 50,000) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 743,623 Bank debt 2022: € 743,623 First fiscal year in the series	€ 643,603 Bank debt 2023: € 643,603 ▼ 13% vs 2022 (€ 743,623) Favourable step	€ 553,571 Bank debt 2024: € 553,571 ▼ 14% vs 2023 (€ 643,603) Favourable step	€ 468,476 Bank debt 2025: € 468,476 ▼ 15% vs 2024 (€ 553,571) Favourable step	▼ 15%
Balance sheet total	€ 1,165,559 Balance sheet total 2022: € 1,165,559 First fiscal year in the series	€ 1,066,647 Balance sheet total 2023: € 1,066,647 ▼ 8% vs 2022 (€ 1,165,559) Unchanged	€ 1,032,847 Balance sheet total 2024: € 1,032,847 ▼ 3% vs 2023 (€ 1,066,647) Unchanged	€ 1,028,763 Balance sheet total 2025: € 1,028,763 Unchanged (€ 1,032,847) Unchanged
Employees (FTE)	3.6 Employees (FTE) 2022: 3.6 First fiscal year in the series	3.9 Employees (FTE) 2023: 3.9 ▲ 0.3 vs 2022 (3.6) Unchanged	4.6 Employees (FTE) 2024: 4.6 ▲ 0.7 vs 2023 (3.9) Unchanged	4 Employees (FTE) 2025: 4 ▼ 0.6 vs 2024 (4.6) Unchanged	▼ 0.6

Key figures of PHARMACIE HITTELET, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE HITTELET?

What happened at PHARMACIE HITTELET in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 20, 2026 New annual accounts for financial year 2025: profit of € 52,563 (▲ 29% vs 2024). filed late Source: NBB ↗
Jan 31, 1991 New establishment in Etalle. KBO
Dec 20, 1990 Start of the company according to the CBE. KBO

In short

From € 68,444 profit in 2022 to € 52,563 profit in 2025.

Paid € 78,981 in corporate taxes since 2022.

Best year ever: 2022, with € 68,444 profit.

On average € 100,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

ExpansionPharma 100%

The stake of ExpansionPharma comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMACIE HITTELET

Behind PHARMACIE HITTELET are Joëlle Denis and Olivier Groffy. The shares are held by ExpansionPharma (100%).

Directors

According to the 2025 annual accounts

Joëlle Denis

Director

Also active at: AKT - CCI Luxembourg Belge, Pharmacie Forthomme, Pharmacie BODARD, PHARMADEFI, L.O.J'M, PHARMALORRAINE, ExpansionPharma, DYNAMIC PHARMA +1 more

Olivier Groffy

Director

Also active at: Pharmacie Forthomme, Pharmacie BODARD, PHARMADEFI, L.O.J'M, PHARMALORRAINE, ExpansionPharma, DYNAMIC PHARMA, delta SUD PHARMA

Shareholders

ExpansionPharma

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Lenclos 72 box A

6740 Etalle

2.051.344.617

Lenclos 72 A

6740 Etalle

Active since 31 January 1991

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.

All companies at this address →

UNIT - BGNS

BGNS

€ -2,124 gross margin · 2025

SOCIETE BELGE D'INGENIEURS EXPERTS

€ 39,334 gross margin · 2025

BUREAU GILLET STABILITE

€ 773,427 gross margin · 2025

BUREAU NADIN SOL

€ 955,184 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0442.591.697

VAT number

BE 0442.591.697

Registered office

Lenclos 72 bus A, 6740 Etalle

Names & denominations

PHARMACIE HITTELET

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

20 December 1990

Peppol

Active · Active since 26 Jan 2026

Contact

[email protected] +3263455192

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE HITTELET

Warning lights

Financials

What happened to PHARMACIE HITTELET?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions